Ajolote Azul sells kits and coordinates genetic studies for your patients. This page summarizes how we operate in Mexico; it does not replace a commercial agreement or the performing laboratory’s documentation.
COFEPRIS
AJOLOTE AZUL GENOMICS, S.A.P.I. de C.V. has an operating notice with the Federal Commission for Protection against Sanitary Risks (COFEPRIS), under form FF-COFEPRIS-02.
We hold a COFEPRIS operating notice for retail sale of medical devices. That notice confirms operating notification; it does not make us a clinical laboratory or certify analytical results.
This notice confirms operating notification with COFEPRIS. It does not replace product-specific authorizations, clinical laboratory permits, or certification of results or services.
Testing is performed by contracted third-party laboratories depending on the product (e.g. nutrigenetics/pharmacogenetics or sequencing). Accreditations (CLIA, CAP, ISO 15189, or others) belong to the laboratory that processes each study. We will publish details per product once verified documentation is available; until then, see our privacy notice or request a technical sheet from our team.
Tumor and clinical sequencing tests require coordination with the treating team. Results are supportive; they do not replace diagnosis, pathology, or treatment decisions. We avoid promising survival rates or other clinical outcomes in advertising.
The referral program is intended for patients and consumers (family, friends). It is not a per-patient payment scheme for healthcare professionals. For institutional or clinic agreements, contact us directly.